Health

Kenyan-based Doctors Design Innovative Device To Ease Menstrual Pain

Published

2 years ago

April 6, 2022

A team of medical experts based in Nairobi, Kenya, has designed an innovative device that helps reduce menstrual pains for women who usually experience serious unease during their menstrual cycle.

NTV Kenya notes on Wednesday that the gadget which is already in circulation at a moderate price has leads that are connected to some sticky pads called electrodes, which help deliver small electrical impulses to the painful area of a woman’s body and subsequently ease the pain.

One of the leading innovators of the device, who is also the chief executive and co-founder of Swift Wellness, Peter Arina, says watching his friend struggle with menstrual pain gave him chills mired in sympathy, prompting him to devise a healing solution.

“The device has leads connected to sticky pads called electrodes. To relieve pain, you attach the pads directly to your skin and turn the device on. The pads will deliver small electrical impulses to the area in pain,” expounds Arina.

According to the innovators, the electrical impulses are capable of reducing the pain signals going to the spinal cord and brain, which may help relieve pain and relax muscles. They may also stimulate the production of endorphins, which are the body’s natural painkillers.

“Depending on the pan impulse, the client regulates the impulse on the device,” Arina says.

The health informatics expert reveals that the device’s working mechanism is inspired by a science called gateway control theory, which dictates that in the human body, an external impulse is given priority over an internal impulse.

During menses, the pain from the menstrual periods is the internal impulse, and it travels all the way to the brain such that when you place the electrodes and the impulse transmission starts, the external impulse is sent to the brain, which forces it to focus on the external impulse, thereby reducing pain from the abdomen.

A co-author of the invention and general practitioner at Karen Hospital, Dr Jane Wavinya, describes the menstrual agony, which in scientific terms is referred to as primary dysmenorrhea, as a thing of serious concern for the womenfolk.

She said, “During menstrual periods, there are hormones produced called prostaglandins that cause pain. Pain is also caused by uterine contractions and ischaemia, which results from a mechanism where the blood vessels in the uterus constrict, reducing blood supply to the uterus.”

She noted that women with a tendency to produce more blood clots are also predisposed to more pain because the uterus has to contract more to expel these blood clots. She explains that besides disrupting the pain pathway to the brain, the electrical stimulation also stimulates the production of endorphins, the feel-good hormones which relieve pain and boost moods.

“We have sold 207 units so far. We have received orders in the evenings from clients who are stuck to their seats because of the pain. We have made deliveries at night, and we have had to deal with clients agitated because of pain,” says Mr Arina.

Although it is safe for most people, experts recommend that pregnant women should avoid using TENS in the abdominal and pelvic regions while applying electrodes to the head or neck of people with epilepsy as this could induce seizures.

People with heart problems and those with another type of electrical implant should also avoid it. The duration of pain relief after using the TENS unit can vary.

Some people may experience pain as soon as they switch off the device while others experience adequate relief for up to 24 hours. Children and teenagers under 16 are exempt from using the device, and it cannot be used underwater.

The device, which comes with a manual, its electrodes and a charger, costs Sh3,500, while its battery lasts for six hours if used continuously and you have to charge it fully to use it.

“Use it for 30 minutes, take a one-hour break, and use it again depending on your pain. Pressing on the M (mode) button, you can adjust the frequency depending on your pain. You can use it at work, working out, and even while sleeping,” says Dr Wavinya.

Dubbed Jolly, the device is a transcutaneous electric nerve stimulator that relieves period pain.

An Embakasi resident, Jacinta Nzyuko, who tried the device on her, told Health Nation that ”when she attached the electrodes of the device on her lower tummy, it gave vibrations that felt like a massage. In less than 10 minutes, the pain had subsided.

Nzyuko said she had been using it ever since.

Source: Health Nation

Health

AUTISM: What You Need To Know

Published

2 weeks ago

April 6, 2024

Editor

By Silver Yeibake

Autism, commonly known as Autism Spectrum Disorder (ASD), is a neurodevelopmental disorder that affects communication, social interaction, and behavior. Autism is referred to as a spectrum condition since it can manifest in a variety of symptoms and abilities. While the actual cause of autism is unknown, evidence suggests that genetic and environmental factors interact to influence its development.

The risk factors include a sibling with autism, advanced age of parents, exposure to certain air pollutants and pesticides before birth, extreme prematurity, mothers with diabetes, immune system disorders or obesity, any difficulty with delivery leading to deprivation of oxygen to the baby’s brain, fever during pregnancy, lack of certain vitamins minerals during pregnancy, and certain genetic conditions, such as Down, fragile X, and Rett syndromes.

“Risk factors can not on their own cause a disease. However, they can increase the likelihood of that disease in a person.”

It is important to know that contrary to trending claims online, there is no scientific or medical evidence that vaccines or consumption of sugar are risk factors for autism.

Autism is defined by difficulties in social interaction and communication. Individuals with autism may struggle to grasp social cues, maintain eye contact, and engage in typical back-and-forth conversations. Some people may also engage in meaningless, repetitive actions, such as hand-flapping or rocking, and have strong interests in specific areas.

It is essential to remember that autism is a lifelong diagnosis, but with early intervention and adequate care, people with autism can live fulfilling lives.
Autism treatment frequently includes behavioral therapy, speech therapy, occupational therapy, and social skills training. Each individual with autism is unique, thus interventions should be tailored to meet their personal needs and strengths.

In spite of the difficulties that autism can cause, many people with autism possess unique talents and abilities. Some people may succeed in fields such as music, art, mathematics, or programming, thus it is important for society to acknowledge and honor the qualities and achievements of people with autism.

In summary, autism is a complicated and diverse disorder that affects individuals in various ways. By raising autism knowledge, understanding, and acceptance, we can build a more inclusive society in which people with autism can thrive and attain their full potential.

Dr. Yeibake, Weriwoyingipre Silver.
Senior Registrar,
Faculty Of Pediatrics,
WACP

Health

Don Confirms ‘Zobo’ As Antihypertensive Therapy

Published

1 month ago

March 10, 2024

Editor

The Deputy Vice Chancellor, University of Nigeria Enugu Campus, UNEC, Prof. Daniel Nwachukwu, after research findings and clinical trials in both animals and human, has confirmed that Hibiscus Sabdariffa, popularly called ‘zobo’ drinks, has all the curative potentials as an antihypertensive therapy.

Nwachukwu, who is a Professor of Cardiovascular Physiology in the university, stated that the antihypertensive effectiveness of the Hibiscus Sabdariffa (zobo) was comparable to those of known antihypertensive drugs that are popular in the retail pharmacies, adding that zobo’s availability, cheapness and absence of side effects make it attractive as an alternative therapeutic agent in mind to moderate hypertensive subjects.

He however cautioned that care should be applied to avoid abuse in the consumption of Hibiscus Sabdariffa (zobo), adding that the therapy could interfere with some anti-malaria drugs while its high dose was also reported to have toxic effects on the liver and kidney.

Nwachukwu’s discoveries were contained his 201st Inaugural Lecture of the University of Nigeria with the topic “The Marriage Between the Cardiovascular System and Hibiscus Sabariffa: Let no One Put Asunder,” delivered at the moot court hall, Law faculty of the University of Nigeria, Enugu campus.

The DVC warned that Hibiscus Sabariffa consumption is not recommended for persons with low blood pressure because of its well established hypotensive action, advising that during combined therapy with antihypertensive drugs, the blood pressure, BP, must be carefully monitored.

He recommended that industrialists and investors should support large scale production of Hibiscus Sabariffa beverage and its distribution to rural communities in Nigeria, particularly since the raw materials (Hibiscus Sabariffa calyx and water) are cheap and readily available.

According to Nwachukwu, “This lecture is intended to draw the public attention to our research efforts and unveiling the antihypertensive ability of Hibiscus Sabariffa which is called zobo in our common parlance. What we used for our studies was the same concentration as the locally produced zobo, and we found out that it exerted significant antihypertensive ability, in some cases even higher than the antihypertensive drugs and also did combination therapy with other antihypertensive drugs.

“What is significant is that this zobo is within us, it’s very cheap and it does not have any side effects compared to other antihypertensive agents. The raw material is just to buy zobo, prepare it under hygienic conditions, boil water and put it, sieve it and drink. It may have a sour taste but we do not encourage people to add things like pineapple or sugar in order to make it sweet, because once you do that, you are diluting or reducing its antihypertensive effectiveness.

“We have demonstrated it, both in animal studies and in humans. We are the first to do clinical trials, using mild to moderate antihypertensive Nigerians and we found it very useful. Some of the results show that one can actually use it and we equally saw that you can use it to prevent even diabetes from occurring because it reduces the rise in glucose level.”

Vice Chancellor of the University, Professor Charles Igwe while summarizing the lecture said that the lecture was in three dimensions; one on health grounds, another in academics and the third an economic value.

“Its economic in the sense that we can also begin to use what God has given us to make money. Maybe because God gave us everything in abundance in this country, we don’t recognize the simplest things God gave us in our environment. Therefore, what we are saying is that we should begin to, at all these pure water productions and incorporate zobo production so as to make money out of it.

“The university has made its contribution through our laboratories and it’s now left for the business community and the industries to come and buy into it and start widening it and make it very economic,” Igwe suggested.
Vanguard

Health

Glaucoma: What You Need To Know

Published

2 months ago

March 8, 2024

Editor

By Silver Yeibake

Hi, did you know that Tuesday 12th March, 2024 is world Glaucoma day?Kindly avail yourself of this opportunity to learn about this important health issue as presented below:

Glaucoma is a dangerous eye disorder that damages the optic nerve, causing visual impairment or permanent blindness if not treated.
The optic nerve transmits visual information from the eye to the brain. Damage to this nerve might cause gradual visual loss that is not immediately obvious.

Worldwide, this disease affects 67 million people and contributes 6.7 million of blindness in this population. Glaucoma is the leading cause of blindness in the world.
The total number of cases is expected to increase to 111 million by 2040. Males are slightly more affected than females.

One of the basic causes of glaucoma is an increase in intraocular pressure (pressure within the eyeball), which can eventually damage the optic nerve (the nerve that makes seeing possible). This increase in pressure could be caused by an accumulation of aqueous humor, the fluid that nourishes the eye.

FROM THE AUTHOR: Food Poisoning: What You Need To Know

There are several forms of glaucoma, including open-angle glaucoma, angle-closure glaucoma, normal-tension glaucoma, and secondary glaucoma, each with unique characteristics and treatment choices.

Some of the risk factors for glaucoma include sustained elevation of intraocular pressure, family history of glaucoma, race (African, Asian), short-sightedness, long-sightedness, age over 50, previous eye injury or surgery, hypertension, diabetes mellitus, migraines, and prolonged steroid therapy.

Glaucoma symptoms may not appear until the problem has advanced sufficiently, therefore regular eye checks are essential for early detection. Blurred vision, eye pain, nausea, and light halos are some of the most frequent glaucoma symptoms. However, these symptoms might be mild or readily misinterpreted as other eye problems, emphasizing the significance of regular eye examinations.

Glaucoma treatment tries to reduce intraocular pressure and protect the optic nerve from further damage. This can be accomplished using a variety of approaches, including prescription eye drops, oral medicines, laser therapy, and surgical procedures. Treatment options are determined on the kind and severity of glaucoma, as well as personal characteristics such as overall health and medical history.

To summarize, glaucoma is a serious eye disorder that requires timely diagnosis and treatment to prevent irreversible vision loss. Regular eye examinations, early detection, and commitment to treatment plans are critical for protecting vision and eye health in glaucoma patients.
Thank you.

Dr. Yeibake, Weriwoyingipre Silver, a
Senior Registrar, Faculty Of Pediatrics, West Africa College of Physician (WACP), writes from Yenagoa, Bayelsa State.